Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other financing activities (2020 - 2023)

Historic Other financing activities for Tango Therapeutics (TNGX) over the last 2 years, with Q4 2023 value amounting to $63000.0.

  • Tango Therapeutics' Other financing activities changed N/A to $63000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $7.2 million, marking a year-over-year change of. This contributed to the annual value of $241000.0 for FY2023, which is 291250.0% up from last year.
  • Tango Therapeutics' Other financing activities amounted to $63000.0 in Q4 2023.
  • Tango Therapeutics' Other financing activities' 5-year high stood at $3.6 million during Q3 2020, with a 5-year trough of $63000.0 in Q4 2023.